Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Enhertu Gets Breakthrough Therapy Tag for 2nd Line Breast Cancer
October 5, 2021
- Ferring Rolls Out Ovulation Inducer Rekovelle in Japan
October 5, 2021
- “Human Error” Is to Blame for Contamination of Moderna COVID-19 Vaccines: Report
October 4, 2021
- Sumitomo Dainippon, Otsuka Ink Global Collaboration for 4 Neuropsychiatric Drugs
October 1, 2021
- JCR Hooks Up with Takeda on Global Expansion of Hunter Syndrome Drug
October 1, 2021
- Asahi Kasei Files Antifungal Cresemba in Japan
October 1, 2021
- Santen, Singapore National Eye Centre Team Up on Training Program for Eye Care Providers
October 1, 2021
- Sanofi Files Sakigake-Designated Olipudase Alfa in Japan for Acid Sphingomyelinase Deficiency
October 1, 2021
- Fujifilm, Australian Startup Join Hands for Contract Manufacturing of iPS Cell-Derived Regenerative Medicine Products
October 1, 2021
- Shionogi Chief Expresses Eagerness for COVID-19 Drug Rollout, PII/III to Wrap Up by Year-End
September 30, 2021
- PeptiDream Bags Milestone Payments from Janssen for Licensing Peptide Discovery Platform Technology
September 30, 2021
- Gilead Seeks Label Expansion for Epclusa in Japan
September 29, 2021
- Shionogi Out-Licenses Ultra-Long-Acting HIV Drug to ViiV
September 29, 2021
- Shionogi Kicks Off Japan PII/III Trial for Oral COVID-19 Drug
September 29, 2021
- Eisai/Biogen Begin US Rolling Submission for Alzheimer’s Med Lecanemab
September 28, 2021
- Takeda’s Cell Therapy Alofisel Approved in Japan
September 28, 2021
- ASKA Earns Japan Rights to Takeda’s Relugolix Combo Drug
September 28, 2021
- ASKA Retracts Japan Application for Uterine Fibroid Med Ulipristal
September 28, 2021
- Astellas, Tohoku University Extend Collaboration for New Healthcare Solutions
September 27, 2021
- Startup Headed by Ex-Biogen Japan Chief Working to Develop New Alzheimer’s Drugs Using Photocatalysts
September 27, 2021
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…